Search PubMed⌕ Search

PubMed · 10738495

Variability within general practitioner prescribing over time.

Abstract

AIMS: We have described intra-general practitioner (GP) prescribing variability over time in terms of volume, cost and average item cost of prescription items, within New Zealand general practice. METHODS: Longitudinal data over the financial years 1992-94 were studied for two GP samples. Prescription data for a regional sample of 305 GPs were obtained for the first six months (January to June) from the New Zealand pharmaceutical pricing office, Health Benefits Limited. Prescription data from a second national sample of 74 GPs were obtained from the PreMeC prescription analysis (PAS) database of GPs who had participated in three consecutive September to December prescription analyses. The coefficient of variation was used to measure the intra-GP variability over time in total prescription cost, volume of prescription items and average prescription item cost. RESULTS: The median intra-GP variability over time for the regional GP sample, based on reimbursement data, was 9% in total cost, 9% in total volume and 5% in average item cost. The median intra-GP variability in the national sample was very similar to the regional sample when based on reimbursement data, but when PAS data were used the variability was 16% in total cost, 17% in total volume and 8% average item cost. CONCLUSIONS: The year-on-year, intra-GP variability for cost was 9%, for volume 9-10% and for average item cost 5-6%. Pharmaceutical budget estimates should reflect year-to-year intra-GP prescribing variability of the order of 9%.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

N Bishop, T Maling. 2000-01-28. Variability within general practitioner prescribing over time.. https://pubmed.ncbi.nlm.nih.gov/10738495/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Re-examining 'professionalism' in pharmacy: a South African perspective.

Although defining itself as a patient-centred profession, private sector (community and private hospital) pharmacy often appears to be that of a product-for-profit centred occupation. This perception has been at the core of the medical profession's attempts to reduce the professional autonomy of pharmacy, and has appeared at the forefront of the South African Department of Health's positioning of private sector pharmacy. Using as a starting point the debate surrounding attempts by the South African Minister of Health to regulate the price of medicines, I propose that the present negative positioning of private sector pharmacy in South Africa could be ameliorated by pharmacy practice that evidences a redefined understanding of professionalism.

Drug Costs↗